Concentric Consulting helps to deliver the world’s first coronavirus Human Challenge Study

Concentric Consulting Ltd has been working for the last 8 months under secondment with the UK Governments Vaccine Task Force in program management and “facilities delivery” roles. Working with viral challenge studies services partners hVIVO, Imperial College London, and the Royal Free London NHS Foundation Trust to prepare for the study and the development of specialist units needed to undertake the £33.6 million investment Human Challenge Study.

UK Government press release:
World’s first coronavirus Human Challenge study receives ethics approval in the UK

The UK will be the first country in the world to run a Covid-19 human challenge study, following approval from the UK’s clinical trials ethics body. The First Covid-19 human challenge study will begin within a month, after receiving ethics approval in the same week the UK hits target of offering first dose to 15 million people. Up to 90 volunteers aged 18 – 30 years will be exposed to Covid-19 in a safe and controlled environment to increase understanding of how the virus affects people.

Backed by a £33.6 million UK government investment, the first-of-its-kind study for this virus will involve establishing the smallest amount of virus needed to cause infection, which will give doctors greater understanding of Covid-19 and help support the pandemic response by aiding vaccine and treatment development.

Due to begin in the next few weeks, it will involve up to 90 carefully selected, healthy adult volunteers being exposed to the virus in a safe and controlled environment. The researchers are also working very closely with the Royal Free Hospital and the North Central London (NCL) Adult Critical Care Network to ensure the study will not impact on the NHS’ ability to care for patients during the pandemic. The study will not begin without their go-ahead.

Full press releases – click the links below:

Contact us to see how we could help your people, your teams, and your business.